Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Rating of Moderate Buy by Analysts

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average […]

Related Keywords

Hong Kong ,United States ,America ,Jeff Cislini ,Stephen Michael Kelsey ,Jpmorgan Chase Co ,Hong Kong Ltd ,Shell Asset Management Co ,Revolution Medicines Inc ,Securities Exchange Commission ,Us Bancorp ,Nasdaq ,Revolution Medicines Company Profile ,Revolution Medicines ,Get Free Report ,General Counsel Jeff Cislini ,Exchange Commission ,Kong Ltd ,Asset Management ,Get Free ,Revolution Medicines Daily ,Nasdaq Rvmd ,Rvmd ,Medical ,Ratings ,Consensus ,